首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Increased expression of TNF ligand-related molecule 1A and death receptor 3 in bladder tissues of patients with painful bladder syndrome/interstitial cystitis
【2h】

Increased expression of TNF ligand-related molecule 1A and death receptor 3 in bladder tissues of patients with painful bladder syndrome/interstitial cystitis

机译:疼痛性膀胱综合征/间质性膀胱炎患者膀胱组织中TNF配体相关分子1A和死亡受体3的表达增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Members of the tumor necrosis factor (TNF) superfamily have been revealed to be associated with painful bladder syndrome/interstitial cystitis (PBS/IC). TNF ligand-related molecule 1A (TL1A) and its receptor, death receptor 3 (DR3), belong to the TNF superfamily and have been implicated in chronic inflammatory diseases. Bladder biopsies from 8 female patients clinically diagnosed with PBS/IC according to the National Institute for Diabetes and Digestive and Kidney Diseases criteria and 8 female bladder carcinoma control patients were investigated to test the protein and mRNA expression levels of TL1A and DR3 using western blotting and real-time RT-PCR. The protein level ratio of TL1A to β-actin (IC, 0.65±0.03 vs. controls, 0.25±0.02, P<0.001) and of its receptor DR3 to β-actin (IC, 0.66±0.06 vs. controls, 0.27±0.02, P<0.001) were observed to be significantly higher in the patients with IC. The real-time RT-PCR ΔCts of TL1A minus GAPDH (IC, 7.60±0.52 vs. controls, 10.08±0.32, P<0.001) and the DR3 minus GAPDH (IC, 6.68±0.60 vs. controls, 8.99±0.61, P=0.017) were observed to be significantly lower in the patients with IC, suggesting that the mRNA levels of TL1A and DR3 were higher in the PBS/IC patients. The protein and mRNA expression of TL1A and DR3 are upregulated in the bladder tissues of PBS/IC patients and may be involved in inflammation and apoptosis in PBS/IC.
机译:肿瘤坏死因子(TNF)超家族的成员已被发现与疼痛性膀胱综合征/间质性膀胱炎(PBS / IC)有关。 TNF配体相关分子1A(TL1A)及其受体死亡受体3(DR3)属于TNF超家族,与慢性炎症性疾病有关。根据美国国家糖尿病与消化与肾脏病研究所的标准对8例临床诊断为PBS / IC的女性患者的膀胱活检和8例女性膀胱癌对照患者进行了研究,以利用Western印迹法和ELISA检测TL1A和DR3的蛋白质和mRNA表达水平。实时RT-PCR。 TL1A与β-肌动蛋白的蛋白质水平比(IC,相对于对照组为0.65±0.03,0.25±0.02,P <0.001)以及其受体DR3与β-肌动蛋白的蛋白质水平比(IC,相对于对照组,0.66±0.06对,0.27±0.02 ,P <0.001)在IC患者中观察到明显更高。 TL1A负GAPDH(IC,7.60±0.52 vs.对照,10.08±0.32,P <0.001)和DR3负GAPDH(IC,6.68±0.60 vs.对照,8.99±0.61,P)的实时RT-PCRΔCts = 0.017)在IC患者中观察到明显更低,这表明TL1A和DR3的mRNA水平在PBS / IC患者中更高。 TL1A和DR3的蛋白质和mRNA表达在PBS / IC患者的膀胱组织中上调,并可能参与PBS / IC的炎症和细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号